BioMarin drops 17% after Ascendis data seen as threat to Voxzogo
hapabapa/iStock Editorial via Getty Images BioMarin Pharmaceuticals (NASDAQ:BMRN) is Down ~17% On Monday, it became known that an achondroplasia candidate ...
Tag: Ascendis
Ascendis shares plunge after FDA finds flaws in TransCon filing
grandparents Ascendis Pharma (ASND) said the US Food and Drug Administration (FDA) identified deficiencies in the company's new drug application ...
Recommended.
